Louisissippi

Leadership Team and Participants

Primary Contact

Maritza Izquierdo
Fresenius Health Partners
maritza.izquierdo@fmc-na.com
(512) 277-6565

Maria Radonova
Integrated Care Group,
Fresenius Health Partners
Actuary

Clinical Leadership Contact

Terry Ketchersid, MD
Integrated Care Group,
Fresenius Medical Care North America
terry.ketchersid@fmc-na.com
(512) 277-6565

Maureen Bernacki
Integrated Care Group
Finance

Facilities

BIO-MEDICAL APPLICATIONS OF LOUISIANA, LLC
BIO-MEDICAL APPLICATIONS OF MISSISSIPPI, INC.
FRESENIUS MEDICAL CARE ADAMS COUNTY HOME, LLC
FRESENIUS MEDICAL CARE CAPITAL CITY, LLC
FRESENIUS MEDICAL CARE CHALMETTE, LLC
FRESENIUS MEDICAL CARE LAKE FOREST, LLC
FRESENIUS MEDICAL CARE SW JACKSON HOME, LLC
LAKELAND HOME PROGRAM, LLC
NNA OF LOUISIANA, LLC
RCG MISSISSIPPI, INC.
RCG OXFORD HOME THERAPIES, LLC
RENAL CARE GROUP TUPELO, LLC
RENEX DIALYSIS FACILITIES, INC.

Participants

Central Nephrology Clinic, PLLC
Alisha Parker
Ami R. Patel
Charisma Cummings
Daphne M. Bilbrew
Derrick H. Tesseneer
Dixie Brown
Francis M. Phillippi IV
Jacqueline Boyd
Lee M. Ferguson
Lindsey T. Norris
Mark N. Klein
Mohit Ahuja
Naveen S. Sandhu
Sohail Abdul-Salim
Steven J. Wagner
David R. Powers, M.D., APMC
Brandon K. Bean, MD
Brenda Ledet, ANP
Charlene Borne, FNP
Christopher Davis
David R. Powers, MD
Kenneth Pitcher
Lafayette Kidney Care
Lauren Herron
Mitul Natu Patel
Nicole Dauzat
Rafal Ciercierski
Rajat Gulati
Robin Bennett
NEPHROLOGY & HYPERTENSION ASSOCIATES, LTD
AMITA MAIBAM, MD
CHRIS D. MILLER, MD
CHRISTY JAGGERS, FNP-BC
FRED A RAYBURN, JR FNP-BC
J. MARTIN LEE, JR, MD
KATHY THOMAS, AGACNP
MARCUS LOUIS BRITTON, MD
MORRIS R HAMILTON, MD
PATRICIA MCKNIGHT, NP
SON G LAM, MD
THOMAS WOOLDRIDGE, MD
TZONKO V MILEV, MD
WILLIAM ELLIOTT, DO
Nephrology Associates, PC
Angela Riley, MD
Ashli Dunn
Christopher LeBrun, MD
Holly Wilds
T. Jason Dunn, DO
Nephrology Center of Excellence
Chad Rossitter
Justin Lege
Matthew Blaine Theriot
New Orleans Nephrology Associates, LLC
Ashwin P. Jaikishen, M.D.
Friedrichs H. Harris, M.D.
Gabriel Rivera-Rodriguez, M.D.
Hui J. Kim, M.D.
Matthew Sanger
Michael C. Touchy, M.D.
Michele Prattini, NP
Miguel F. Molina, M.D.
Shannon Morris, NP
Sharee Encalade, NP
Sherry Rivera, NP
Steven A. Morris, M.D.
Trac T. Le, M.D.
Renal Associates of Baton Rouge, LLC
Basireddy, Mahesh R, MD
Burke, Emily, NP
Cassano, Ronnie, NP
Corona, Raynold, MD
Hebert, Dawn, NP
Hebert, Mitchell, MD
Jones, Judson, NP
Kumbala, Damodar, MD
Landry, Robert, MD
Lewis, Natasha, NP
Louque, Jennifer, NP
Luscy, Christopher P, MD
Murrill, William, MD
O'Neal, Jeremy, MD
Roppolo, Michael, MD
Samuel, Jones, MD
Sim, James S, MD
Smith, Kenneth, MD
Tran, Jessica, NP
Yegge, James, MD

Kidney Care Choices Model Implementation Period Notice of Waiver

The Centers for Medicare and Medicaid Services and the U.S. Department of Health and Human Services’ Office of Inspector General have provided certain waivers of federal fraud and abuse laws in connection with participation during the Implementation Period in the Comprehensive Kidney Care Contracting (“CKCC”) Option of the Kidney Carse Choices (“KCC”) Model (“KCC Implementation Period Waivers”). In accordance with such Waivers, the KCE provides notice that the Implementation Period KCE Activities arrangement described below is being provided under the protection of the KCC Implementation Period Waivers.

Implementation Period KCE Activities: The Board of Managers of Louisissippi Kidney Care Entity, LLC (the “CE”) has duly authorized the following arrangement and has made a bona fide determination that this arrangement is reasonably related to the performance of KCE Activities during the Implementation Period because the arrangement is in preparation for and will promote the future accountability for the quality, cost, and overall care for KCE Beneficiaries. As of October 19, 2021, the KCE has engaged BIO-MEDICAL APPLICATIONS OF LOUISIANA, LLC, a KCE Preferred Provider, to provide certain services and items in preparation for the start of the Performance Year. Such services and items include care coordination and management services, education related to performance under a risked-based financial arrangement, and information technology to improve care processes and to prepare for the assumption of financial risk under the KCC Model.

The KCE will publicly disclose on this website additional arrangements that qualify for the KCC Implementation Period Waivers as they are authorized by its governing board, in compliance with public disclosure requirements.

Company

Fresenius Medical Care Holdings, Inc.
Fresenius Seamless Care
PO Box 162970
Austin, TX 78716-2970

Governing Body

Renal Associates of Baton Rouge, Michael W. Roppolo, MD
Fresenius Health Partners, Maritza Izquierdo
Independent Consumer Advocate, Pete Sullivan